Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / TCG Crossover Management, LLC
Form 13F · Q2 2026

TCG Crossover Management, LLC

CIK 1839948申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$41.6亿
申报组合市值
54
持仓数量
12
Quarters on record
Top 50
持仓数量

TCG Crossover Management, LLC——持仓

共 54 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1ABVX Abivax Sa6.0M−7.3%$8.0亿19.2%
2TNGX Tango Therapeutics Inc9.1M−13.8%$2.8亿6.8%
3CGON Cg Oncology Inc3.7M+0.0%$2.6亿6.3%
4COGT Cogent Biosciences Inc4.9M−1.9%$1.9亿4.5%
5IMVT Immunovant Inc4.5M+0.0%$1.7亿4.1%
6SYRE Spyre Therapeutics Inc1.9M+0.0%$1.7亿4.1%
7DNTH Dianthus Therapeutics Inc1.7M+0.0%$1.6亿3.9%
8MIRM Mirum Pharmaceuticals Inc1.1M+0.0%$1.2亿3.0%
9ZLAB Zai Lab Ltd6.1M—$1.2亿2.8%
10AMLX Amylyx Pharmaceuticals Inc6.2M+0.0%$1.1亿2.7%
11GLUE Monte Rosa Therapeutics Inc4.6M+0.0%$1.1亿2.7%
12BCRX Biocryst Pharmaceuticals Inc11.0M+0.0%$1.1亿2.6%
13VOR Vor Biopharma Inc5.7M+0.0%$1.0亿2.5%
14TYRA Tyra Biosciences Inc3.2M+0.0%$1.0亿2.5%
15DYN Dyne Therapeutics Inc4.6M+0.0%$1.0亿2.5%
16IRON Disc Medicine Inc1.3M+0.0%$9814万2.4%
17RLAY Relay Therapeutics Inc4.3M+0.0%$7995万1.9%
18SVRA Savara Inc12.4M+0.0%$7615万1.8%
19AURA Aura Biosciences Inc9.5M—$6769万1.6%
20RVMD Revolution Medicines Inc340,899−40.9%$6384万1.5%
21TRAX First Tracks Biotherapeutics2.9M—$5825万1.4%
22KOD Kodiak Sciences Inc1.4M+0.0%$5632万1.4%
23AVTX Avalo Therapeutics Inc3.0M+308.6%$5576万1.3%
24LBRX Lb Pharmaceuticals Inc1.4M−21.3%$4697万1.1%
25IPSC Century Therapeutics Inc17.8M+0.0%$4340万1.0%
26TECX Tectonic Therapeutic Inc1.2M+0.0%$4142万1.0%
27XNCR Xencor Inc2.5M+0.0%$3948万0.9%
28SRZN Surrozen Inc1.5M+0.0%$3823万0.9%
29EDIT Editas Medicine Inc11.1M—$3600万0.9%
30MBX Mbx Biosciences Inc650,000+0.0%$3588万0.9%
31PHVS Pharvaris N V1.0M—$3486万0.8%
32SLN Silence Therapeutics Plc3.0M+0.0%$3331万0.8%
33IFRX Inflarx Nv14.5M—$3248万0.8%
34ALT Altimmune Inc10.0M—$3040万0.7%
35JANX Janux Therapeutics Inc1.8M+0.0%$2749万0.7%
36CATX Perspective Therapeutics Inc7.9M+0.0%$2699万0.6%
37AGMB Agomab Therapeutics Nv2.1M+0.0%$2665万0.6%
38BHVN Biohaven Ltd1.8M−61.6%$2649万0.6%
39AKTS Aktis Oncology Inc696,560—$2245万0.5%
40ALEC Alector Inc10.0M+0.0%$2010万0.5%
41FORTE BIOSCIENCES INC Forte Biosciences Inc920,000—$1955万0.5%
42MNPR Monopar Therapeutics Inc203,327+53.9%$1883万0.5%
43OCUL Ocular Therapeutix Inc1.6M+0.0%$1618万0.4%
44ADCT Adc Therapeutics Sa11.4M+0.0%$1219万0.3%
45ALXO Alx Oncology Hldgs Inc5.7M−56.5%$1171万0.3%
46TRDA Entrada Therapeutics Inc1.1M−53.7%$780万0.2%
47CGEM Cullinan Therapeutics Inc406,786+0.0%$741万0.2%
48ARVN Arvinas Inc707,098−70.4%$588万0.1%
49KRRO Korro Bio Inc416,301+0.0%$549万0.1%
50RACC Research Alliance Corp Iii500,000—$535万0.1%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。